Free Trial
→ Forget AI Stocks — This Device Will REPLACE the Microchip (From Banyan Hill Publishing) (Ad)tc pixel Free CRNX Stock Alerts

Trading of Crinetics Pharmaceuticals was halted at 05:18 PM EST due to "News pending".

Crinetics Pharmaceuticals (CRNX) SEC Filings & 10K Form

Crinetics Pharmaceuticals logo
$35.89 +0.71 (+2.02%)
Closing price 04:00 PM Eastern
Extended Trading
$36.18 +0.29 (+0.81%)
As of 05:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Crinetics Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
09/08/2025
4:36 PM		Crinetics Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SCHEDULE 13G
09/04/2025
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025
3:41 PM		Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2025
3:44 PM		Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2025
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2025
3:24 PM		Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2025
9:34 AM		Crinetics Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
06/26/2025
3:16 PM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
3:30 PM		Crinetics Pharmaceuticals (Filer)
Form DEF 14A
04/23/2025
3:33 PM		Crinetics Pharmaceuticals (Filer)
Form DEFA14A
04/23/2025
3:36 PM		Crinetics Pharmaceuticals (Filer)
Form ARS
04/07/2025
10:52 AM		Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
03/21/2025
5:31 PM		Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:32 PM		Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:33 PM		Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:34 PM		Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Schilke Tobin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/27/2025
3:23 PM		Crinetics Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:23 PM		Crinetics Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:10 PM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:13 PM		Crinetics Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
7:50 AM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
9:25 AM		Crinetics Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:06 AM		Crinetics Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:23 AM		Crinetics Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
01/30/2025
8:33 PM		Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/29/2025
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/29/2025
3:30 PM		Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/14/2025
4:02 PM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Kalofonos Isabel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
6:34 AM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Kalofonos Isabel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2024
3:30 PM		Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:32 PM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
7:07 AM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
3:06 PM		Crinetics Pharmaceuticals (Subject)
Struthers Richard Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:55 PM		Crinetics Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:46 PM		Crinetics Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
11/12/2024
1:26 PM		Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM		Crinetics Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/04/2024
10:20 AM		Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/17/2024
11:47 AM		Crinetics Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/16/2024
3:08 PM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
4:13 PM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
3:35 PM		Crinetics Pharmaceuticals (Filer)
Form 424B5
10/08/2024
4:01 PM		Crinetics Pharmaceuticals (Filer)
Form 424B5
10/07/2024
6:55 AM		Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:01 PM		Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2024
3:23 PM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
3:06 PM		Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CRNX) was last updated on 9/25/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...
SmartAsset | Sponsoredtc pixel
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel
Strange crypto pattern discovered by 40-person research team
Something unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...
Crypto Swap Profits | Sponsoredtc pixel
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel